Analysis Article • May 22
Have your own idea? Try our Stock Screener
Brazilian (BOVESPA) Healthcare Sector Analysis
UpdatedMay 31, 2026
DataAggregated Company Financials
Companies16
- 7D0.9%
- 3M-11.6%
- 1Y-10.8%
- YTD-7.2%
The Healthcare is pretty flat in the last 7 days, but Bradsaúde has stood out, gaining 5.2%. As for the longer term, the industry has declined 11% in the last year. Earnings are forecast to grow by 27% annually.
Sector Valuation and Performance
Has the Brazilian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 31 May 2026 | R$158.9b | R$154.4b | R$2.4b | 13.5x | 66.1x | 1x |
| Tue, 28 Apr 2026 | R$137.4b | R$154.0b | R$2.9b | 12.9x | 48.1x | 0.9x |
| Thu, 26 Mar 2026 | R$136.7b | R$155.3b | R$3.7b | 12.6x | 36.6x | 0.9x |
| Sat, 21 Feb 2026 | R$153.3b | R$152.1b | R$1.8b | 13.9x | 83.1x | 1x |
| Mon, 19 Jan 2026 | R$140.6b | R$152.1b | R$1.8b | 12.1x | 76.2x | 0.9x |
| Wed, 17 Dec 2025 | R$157.5b | R$152.1b | R$1.8b | 12.1x | 85.3x | 1x |
| Fri, 14 Nov 2025 | R$164.6b | R$152.1b | R$3.3b | 12.9x | 49.6x | 1.1x |
| Sun, 12 Oct 2025 | R$145.7b | R$149.9b | R$2.5b | 11.7x | 58.3x | 1x |
| Tue, 09 Sep 2025 | R$149.1b | R$149.9b | R$2.5b | 12.1x | 59.7x | 1x |
| Thu, 07 Aug 2025 | R$137.8b | R$150.0b | R$2.1b | 11.8x | 66.7x | 0.9x |
| Sat, 05 Jul 2025 | R$139.2b | R$149.5b | R$2.0b | 11.3x | 68.3x | 0.9x |
| Mon, 02 Jun 2025 | R$148.6b | R$149.5b | R$2.0b | 10.7x | 72.9x | 1x |
| Wed, 30 Apr 2025 | R$130.2b | R$147.7b | R$1.9b | 10.9x | 70.1x | 0.9x |
| Fri, 28 Mar 2025 | R$120.7b | R$150.6b | R$5.3b | 10.8x | 22.9x | 0.8x |
| Sun, 23 Feb 2025 | R$123.5b | R$146.7b | R$4.7b | 11x | 26.5x | 0.8x |
| Tue, 21 Jan 2025 | R$112.6b | R$146.7b | R$4.7b | 10.6x | 24.1x | 0.8x |
| Thu, 19 Dec 2024 | R$113.3b | R$146.7b | R$4.7b | 11.2x | 24.3x | 0.8x |
| Sat, 16 Nov 2024 | R$131.3b | R$147.6b | R$5.4b | 12.2x | 24.1x | 0.9x |
| Mon, 14 Oct 2024 | R$142.3b | R$144.9b | R$4.4b | 10.7x | 32.3x | 1x |
| Wed, 11 Sep 2024 | R$158.7b | R$144.9b | R$4.4b | 11.6x | 36.1x | 1.1x |
| Fri, 09 Aug 2024 | R$149.1b | R$143.4b | R$4.1b | 11.7x | 36x | 1x |
| Sun, 07 Jul 2024 | R$142.2b | R$142.9b | R$4.2b | 11.8x | 34x | 1x |
| Tue, 04 Jun 2024 | R$142.8b | R$142.9b | R$4.2b | 11.4x | 34.2x | 1x |
| Thu, 02 May 2024 | R$138.3b | R$140.1b | R$3.2b | 12.2x | 42.9x | 1x |
| Sat, 30 Mar 2024 | R$141.7b | R$139.6b | R$2.8b | 13.1x | 50.1x | 1x |
| Mon, 26 Feb 2024 | R$143.4b | R$132.9b | R$2.7b | 16.2x | 52.9x | 1.1x |
| Wed, 24 Jan 2024 | R$152.3b | R$135.0b | R$2.9b | 18.8x | 52.8x | 1.1x |
| Fri, 22 Dec 2023 | R$165.2b | R$135.0b | R$2.9b | 20.5x | 57.3x | 1.2x |
| Sun, 19 Nov 2023 | R$161.6b | R$135.0b | R$2.9b | 14.9x | 55.9x | 1.2x |
| Tue, 17 Oct 2023 | R$149.0b | R$126.1b | R$2.7b | 18.2x | 54.2x | 1.2x |
| Thu, 14 Sep 2023 | R$175.1b | R$126.1b | R$2.7b | 20.1x | 63.7x | 1.4x |
| Sat, 12 Aug 2023 | R$187.0b | R$125.0b | R$2.7b | 28.2x | 69.4x | 1.5x |
| Mon, 10 Jul 2023 | R$185.4b | R$116.7b | R$2.8b | 17.1x | 65.8x | 1.6x |
| Wed, 07 Jun 2023 | R$173.7b | R$116.7b | R$2.8b | 16.5x | 61.4x | 1.5x |
Price to Earnings Ratio
61.4x
Current Industry PE
- Investors are optimistic on the Brazilian Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 66.1x which is higher than its 3-year average PE of 51.4x.
- The industry is trading close to its 3-year average PS ratio of 1.0x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 5.3% per year over the last three years.
- Meanwhile revenues for these companies have grown 9.8% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Brazilian Healthcare sector?
| BR Market | -0.83% | |
| Healthcare | 0.89% | |
| Healthcare Services | 1.33% | |
| Biotech | 1.09% | |
| Medical Equipment | 0.25% | |
| Pharma | -2.60% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 117x.
- Analysts are expecting annual earnings growth of 27.9%, which is higher than its past year's earnings growth of 1.2% per year.
- Investors are most pessimistic about the Medical Equipment industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 0.63x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 28% over the next 5 years.
- This is better than its past earnings growth rate of 1.2% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 16% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SAUD3 Bradsaúde | R$13.56 | 5.2% +R$2.0b | 23.3% | PE70.2x | |
| PFRM3 Profarma Distribuidora de Produtos Farmacêuticos | R$7.05 | 9.0% +R$71.1m | -19.2% | PE8.2x | |
| DASA3 Diagnósticos da América | R$3.10 | 1.6% +R$62.5m | 95.0% | PS0.4x | |
| BLAU3 Blau Farmacêutica | R$11.39 | 2.2% +R$55.4m | 5.8% | PE10.8x | |
| HAPV3 Hapvida Participações e Investimentos | R$12.15 | 0.8% +R$47.5m | -71.7% | PS0.2x |
